Explanation of how the number of participants for analysis was determined.
Includes whether analysis was per protocol, intention to treat, or another method.
Also provides relevant details such as imputation technique, as appropriate.

Explanation of how the number of participants for analysis was determined.
Includes whether analysis was per protocol, intention to treat, or another method.
Also provides relevant details such as imputation technique, as appropriate.

Participants analyzed consisted of those participants who had the endpoint data available to be derived.

Reporting Groups

Description

Placebo

placebo 20 mg three tid for 12 weeks followed by 60 mg tid for 12 weeks

Sildenafil

sildenafil 20 mg three tid for 12 weeks followed by 60 mg tid for 12 weeks